Adtran Inc. (NASDAQ:ADTN) is set to post its Q316 quarterly earnings results on Tuesday, October 18th. Analysts expect Adtran to post earnings of $0.23 per share and revenue of $110.31 million for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.
Shares of Adtran Inc. (NASDAQ:ADTN) opened at 18.22 on Friday. Adtran Inc. has a 12-month low of $13.92 and a 12-month high of $21.43. The company has a 50-day moving average price of $18.76 and a 200 day moving average price of $18.80. The firm has a market capitalization of $881.81 million, a price-to-earnings ratio of 32.30 and a beta of 0.95.
A number of equities research analysts have recently commented on ADTN shares. MKM Partners reaffirmed a “buy” rating and set a $24.00 price target on shares of Adtran in a research report on Sunday, July 17th. Needham & Company LLC reaffirmed a “buy” rating and set a $22.00 price target on shares of Adtran in a research report on Thursday, July 14th. Three investment analysts have rated the stock with a sell rating, two have assigned a hold rating and six have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $22.05.
A number of hedge funds have recently modified their holdings of the company. Arizona State Retirement System raised its stake in shares of Adtran by 0.8% in the second quarter. Arizona State Retirement System now owns 25,445 shares of the company’s stock worth $475,000 after buying an additional 200 shares in the last quarter. Paloma Partners Management Co acquired a new position in Adtran during the second quarter valued at about $838,000. A.R.T. Advisors LLC acquired a new position in Adtran during the second quarter valued at about $1,060,000. Capstone Investment Advisors LLC acquired a new position in Adtran during the second quarter valued at about $450,000. Finally, Guggenheim Capital LLC raised its position in Adtran by 47.7% in the second quarter. Guggenheim Capital LLC now owns 23,181 shares of the company’s stock valued at $432,000 after buying an additional 7,486 shares in the last quarter. 96.11% of the stock is owned by hedge funds and other institutional investors.
Adtran Company Profile